Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
133
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Glenmark Pharmaceuticals
•
30 Jun 2020 17:12
Glenmark Pharmaceuticals - Earnings Flash - Q4 And FY 2019-20 Results - Lucror Analytics
Glenmark Pharmaceuticals’ Q4/19-20 results were better than expected, with a turnaround in profitability. The improved performance was attributed...
Lucror Analytics
Follow
299 Views
Share
bearish
•
361 Degrees International
•
30 Jun 2020 14:56
Asia HY Trade Recommendations - June 2020 - Lucror Analytics
The Asia HY Trade Recommendations report for the month of June includes a summary of our recommendations. The report also features relative-value...
Lucror Analytics
Follow
275 Views
Share
bullish
•
Softbank Group
•
29 Jun 2020 08:57
Morning Views Asia: Glenmark Pharmaceuticals, Softbank Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
Lucror Analytics
Follow
216 Views
Share
bullish
•
Jubilant Pharma Ltd
•
26 Jun 2020 10:43
Jubilant Pharma: Good Drugs, Fully-Valued Bonds
We initiate our coverage of Jubilant Pharma Ltd (1164252D IN) (JPL) which is ranked top 2-3 global pharmaceutical company in the...
Bondcritic
Follow
381 Views
Share
bullish
•
Hilong Holding
•
23 Jun 2020 08:52
Morning Views Asia: Fosun International, Glenmark Pharmaceuticals, Modernland Realty, Softbank Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
Lucror Analytics
Follow
283 Views
Share
First
Previous
10
11
12
13
14
15
16
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x